Literature DB >> 646847

Studies on the occurrence of circulating immune complexes in vascular diseases.

G Füst, E Szondy, J Székely, I Nánai, S Gerö.   

Abstract

The presence of circulating immune complexes was studied in 347 samples of serum from 212 patients with various vascular diseases. Two quantitative methods (complement-consumption assay and C1q-solubility test) were used for the measurement of the concentration of the complexes. Immune complexes were detected in each group of patients tested (coronary arteriosclerosis, myocardial infarction, cerebral artery sclerosis, arteriosclerosis obliterans, phlebothrombosis, pulmonary infarction). A high proportion of positivity was recorded in myocardial infarction (in 43 patients out of the 94 tested) and in arteriosclerosis obliterans (7 out of 11 cases). The possible pathogenic role of the circulating immune complexes is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646847     DOI: 10.1016/0021-9150(78)90006-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 2.  Immunological aspects of atheroma: a review.

Authors:  R N Poston
Journal:  J R Soc Med       Date:  1979-09       Impact factor: 5.344

3.  An experimental immunocytoma model in /LOU/M/Ws1 X CFY/F1 rats: neoplastic cells as targets of the host's immune apparatus.

Authors:  E Puskás; F Uher; J Gergely; H Bazin
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

4.  Serial measurement of circulating immune complexes in myocardial infarction.

Authors:  E Szondy; Z Mezey; G Füst; J Székely; S Gerö
Journal:  Br Heart J       Date:  1981-07

5.  Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.

Authors:  R L Griffith; G T Virella; H C Stevenson; M F Lopes-Virella
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.